Cassava Stock Analysis

SAVA -  USA Stock  

USD 39.45  0.30  0.75%

The modest gains experienced by current holders of Cassava Sciences created some momentum for investors as it was traded today as low as 38.42 and as high as 41.49 per share. The company directors and management have been quite successful in maneuvering the stock at opportune times to take advantage of all market conditions in December. The stock standard deviation of daily returns for 90 days investing horizon is currently 9.83. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Cassava Sciences partners.
Additionally, take a look at World Market Map.

Cassava Stock Analysis 

 
Refresh
The Cassava Sciences stock analysis report makes it easy to digest most publicly released information about Cassava Sciences and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Cassava Stock analysis module also helps to analyze the Cassava Sciences price relationship with some important fundamental indicators such as market cap and management efficiency.

Cassava Stock Analysis Notes

About 30.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 0.56. Cassava Sciences next dividend is scheduled to be issued on the 13th of December 2012. The entity had a split on the 10th of May 2017. Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Cassava Sciences, Inc. was incorporated in 1998 and is based in Austin, Texas. Cassava Sciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 11 people. To find out more about Cassava Sciences contact Remi Barbier at 512 501 2444 or learn more at https://www.cassavasciences.com.

Cassava Sciences Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Cassava Sciences' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Cassava Sciences or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Cassava Sciences has very high historical volatility over the last 90 days
Cassava Sciences has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (20.83 M) with loss before overhead, payroll, taxes, and interest of (3.05 M).
Cassava Sciences currently holds about 241.52 M in cash with (23.38 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.04.
Latest headline from www.globenewswire.com: NASDAQ SAVA Notice Update in Lawsuit for Investors in Cassava Sciences, Inc. NASDAQ - GlobeNewswire

Cassava Market Capitalization

The company currently falls under 'Mid-Cap' category with current market capitalization of 1.6 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Cassava Sciences's market, we take the total number of its shares issued and multiply it by Cassava Sciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Management Efficiency

The entity has return on total asset (ROA) of (8.78) % which means that it has lost $8.78 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (14.29) %, meaning that it created substantial loss on money invested by shareholders. Cassava Sciences management efficiency ratios could be used to measure how well cassava sciences manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 29th of January, Cassava Sciences shows the Mean Deviation of 5.91, downside deviation of 6.95, and Risk Adjusted Performance of 0.0227. In respect to fundamental indicators, the technical analysis model gives you tools to check existing technical drivers of Cassava Sciences, as well as the relationship between them. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to interpolate and analyze data for nineteen technical drivers for Cassava Sciences, which can be compared to its rivals. Please confirm Cassava Sciences jensen alpha, potential upside, as well as the relationship between the Potential Upside and skewness to decide if Cassava Sciences is priced correctly, providing market reflects its regular price of 39.45 per share. Given that Cassava Sciences has jensen alpha of 0.2998, we suggest you to validate Cassava Sciences's prevailing market performance to make sure the company can sustain itself at a future point.

Cassava Sciences Price Movement Analysis

The output start index for this execution was seven with a total number of output elements of fifty-four. The Mid-point Price over period is an average of Cassava Sciences highest and lowest prices attained during the given period. View also all equity analysis or get more info about midpoint price over period overlap studies indicator.

Cassava Sciences Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Cassava Sciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on Cassava Sciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Cassava Sciences insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Remi Barbier over a month ago via Macroaxis 
Purchase by Remi Barbier of 10000 shares of Cassava Sciences
Remi Barbier over two months ago via Macroaxis 
Exercise or conversion by Remi Barbier of 56030 shares of Cassava Sciences subject to Rule 16b-3
Armistice Capital Llc over three months ago via Macroaxis 
Cassava Sciences exotic insider transaction detected
Robert Gussin over three months ago via Macroaxis 
Exercise or conversion by Robert Gussin of 2801 shares of Cassava Sciences subject to Rule 16b-3
Robert Gussin over three months ago via Macroaxis 
Payment of 1746 shares by Robert Gussin of Cassava Sciences subject to Rule 16b-3
Remi Barbier over six months ago via Macroaxis 
Exercise or conversion by Remi Barbier of 2801 shares of Cassava Sciences subject to Rule 16b-3
Barry Richard over six months ago via Macroaxis 
Cassava Sciences exotic insider transaction detected
Remi Barbier over six months ago via Macroaxis 
Exercise or conversion by Remi Barbier of 56030 shares of Cassava Sciences subject to Rule 16b-3
Sanford Robertson over six months ago via Macroaxis 
Exercise or conversion by Sanford Robertson of 4670 shares of Cassava Sciences subject to Rule 16b-3
Nadav Friedmann over six months ago via Macroaxis 
Exercise or conversion by Nadav Friedmann of 28015 shares of Cassava Sciences subject to Rule 16b-3
Sanford Robertson over a year ago via Macroaxis 
Acquisition by Sanford Robertson of 25000 shares of Cassava Sciences subject to Rule 16b-3
Sanford Robertson over a year ago via Macroaxis 
Acquisition by Sanford Robertson of 10000 shares of Cassava Sciences subject to Rule 16b-3

Cassava Sciences Technical and Predictive Indicators

Cassava Sciences Forecast Models

Cassava Sciences time-series forecasting models is one of many Cassava Sciences' stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Cassava Sciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Cassava Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Cassava Sciences stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Cassava shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Cassava Sciences. By using and applying Cassava Stock analysis, traders can create a robust methodology for identifying Cassava entry and exit points for their positions.
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Cassava Sciences, Inc. was incorporated in 1998 and is based in Austin, Texas. Cassava Sciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 11 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Cassava Sciences to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Portfolio Manager Now

   

Portfolio Manager

State of the art Portfolio Manager to monitor and improve performance of your invested capital
All  Next Launch Module
Additionally, take a look at World Market Map. Note that the Cassava Sciences information on this page should be used as a complementary analysis to other Cassava Sciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Complementary Tools for Cassava Stock analysis

When running Cassava Sciences price analysis, check to measure Cassava Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cassava Sciences is operating at the current time. Most of Cassava Sciences' value examination focuses on studying past and present price action to predict the probability of Cassava Sciences' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Cassava Sciences' price. Additionally, you may evaluate how the addition of Cassava Sciences to your portfolios can decrease your overall portfolio volatility.
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Is Cassava Sciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cassava Sciences. If investors know Cassava will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cassava Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Cassava Sciences is measured differently than its book value, which is the value of Cassava that is recorded on the company's balance sheet. Investors also form their own opinion of Cassava Sciences' value that differs from its market value or its book value, called intrinsic value, which is Cassava Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cassava Sciences' market value can be influenced by many factors that don't directly affect Cassava Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cassava Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine Cassava Sciences value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cassava Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.